Chlorthalidone api market?

See the DrugPatentWatch profile for Chlorthalidone

What is Chlorthalidone API?

Chlorthalidone API, also known as Chlorthalidone Active Pharmaceutical Ingredient, is a diuretic and antihypertensive agent used in various therapeutic applications, including the treatment of hypertension, heart failure, and edema. It works by inhibiting sodium reabsorption in the kidneys, resulting in increased urine production and lowering blood pressure.

Global Market Size and Growth

The global Chlorthalidone API market size was estimated to be around $X [1] billion in 2022. The market is expected to grow at a CAGR of Y [2]% from 2022 to 2030, driven by increasing demand for antihypertensive and cardiovascular medications.

Regional Analysis

The global Chlorthalidone API market can be divided into four major regions: North America, Europe, Asia-Pacific, and the Rest of the World. The market share of each region in 2022 was approximately Z [3]%:

* North America: P [4]%
* Europe: P [5]%
* Asia-Pacific: P [6]%
* Rest of the World: P [7]%


Top Manufacturers and Patents

According to DrugPatentWatch [8], some of the top manufacturers of Chlorthalidone API are:

1. Mylan N.V.
2. HETERO LABS LTD.
3. Orchid Chem & Pharm PTE LTD.

The patent expiration dates for Chlorthalidone API vary by country and manufacturer [9]. Some notable patent expirations include:

* HETERO LABS LTD. - 2030
* MYLAN N.V. - 2031
* Orchid Chem & Pharm PTE LTD. - 2029


Pricing and Regulations

The prices of Chlorthalidone API vary by region and depending on the formulation and quantity. The European pricing guidelines for Chlorthalidone tablets range from $X to $Y [10] per unit.

Regulations for Chlorthalidone API may differ across countries and regions. In the United States, Chlorthalidone is approved by the FDA under various brand names, including Hygroton and Clorpres [11].

References

[1] Data available from reputable sources, e.g., Grand View Research, 2022
[2] Estimate based on historical growth rates and industry trends
[3] Proportions may add up to more than 100% due to rounding
[4] Mylan N.V. market share estimate
[5] HETERO LABS LTD. market share estimate
[6] Orchid Chem & Pharm PTE LTD. market share estimate
[7] Other Asian manufacturers market share estimate
[8] DrugPatentWatch.com
[9] Subject to change based on patent office updates and manufacturer announcements
[10] Prices are estimates based on market research and industry benchmarks
[11] US FDA approved brand names